title: Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
authors.affiliation: From the Fred Hutchinson Cancer Research Center and the University of Washington - both in Seattle (G.H.L.); the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, National Academies of Sciences, Engineering, and Medicine, Washington, DC (G.H.L., H.L.M.); and Vanderbilt University, Nashville (H.L.M.).
authors.forename: Gary H
authors.initials: GH
authors.lastname: Lyman
authors.affiliation: From the Fred Hutchinson Cancer Research Center and the University of Washington - both in Seattle (G.H.L.); the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, National Academies of Sciences, Engineering, and Medicine, Washington, DC (G.H.L., H.L.M.); and Vanderbilt University, Nashville (H.L.M.).
authors.forename: Harold L
authors.initials: HL
authors.lastname: Moses
mesh_terms: D026683:Advisory Committees; D015415:Biomarkers / Q000032:analysis*; D019411:Clinical Laboratory Techniques / Q000592:standards*; D005380:Financing, Government; D023281:Genomics / Q000191:economics / Q000331:legislation & jurisprudence; D006291:Health Policy; D006801:Humans; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D057285:Precision Medicine / Q000191:economics / Q000379:methods; D012109:Research Support as Topic; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration
chemical_list: D015415:Biomarkers